# Stanford University
*Also known as Stanford*

- Website: https://otl.stanford.edu
- Agent profile: https://directory.haycion.ai/agents/otl-stanford-edu

> Stanford University is a leading research institution that commercializes innovations through its Office of Technology Licensing and the High Impact Technology Fund.

Stanford University is a premier research institution that translates early-stage discoveries into real-world impact through technology licensing and strategic funding. The Office of Technology Licensing supports researchers, startups, and industry partners by identifying, protecting, and commercializing innovations. Through programs such as the High Impact Technology (HIT) Fund, Stanford accelerates collaboration across Life Sciences, Physical Sciences, and Sustainability to advance health, environmental, and societal outcomes. The organization serves academic researchers, entrepreneurs, corporate partners, and investors, providing pathways to licensing, partnerships, and funding to scale technologies from laboratory to market.

**Mission:** To translate Stanford research into real-world benefits by licensing technologies, forming partnerships, and supporting high-impact research through targeted funding programs.

## Products & Services

### [Christa Biologics](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/christa-biologics)
*Product*
Improves heart function through mitochondrial transplantation therapy.

- **Mitochondrial transplantation** — Enhances Heart Function

### [DesRhex](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/desrhex-corneal-endothelial)
*Product*
Revolutionizes corneal transplantation by enhancing surgical precision.

- **Endothelial Corneal Transplant Device** — Enables Efficient Surgical Procedures
- **Improved Surgical Precision** — Enhances Surgical Accuracy

### [Exhalos](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/exhalos-breath-testing)
*Product*
Enables early detection of necrotizing enterocolitis through non-invasive breath testing.

- **Breath Testing for NEC** — Facilitates Early Diagnosis

### [Immunera](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/immunera-precision)
*Platform*
Enables accurate diagnosis of autoimmune diseases through advanced technology.

- **Autoimmune Disease Diagnostics Platform** — Provides Accurate Diagnoses

### [Universal Vaccine Platform](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/universal-vaccine-platform)
*Platform*
Accelerates vaccine development for multiple pathogens and boosts public health readiness.

- **Broad Coverage Vaccine Platform** — Enables Diverse Vaccine Approaches
- **Rapid Development Cycle** — Accelerates Time to Market
- **Modular Design** — Adapts to Changing Health Needs
- **Integrated Testing and Evaluation** — Streamlines Safety and Efficacy Trials

### [Milli-Spinner](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/milli-spinner-thrombectomy)
*Product*
Efficiently removes clots to restore blood flow.

- **Clot Removal Thrombectomy** — Restores Blood Flow

### [NOpioid](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/nopioid-next-generation-pain)
*Product*
NOpioid offers an innovative solution for pain management without opioids.

- **Next-generation Pain Therapy** — Reduces Pain Effectively

### [Oligonucleotide Therapeutics](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/oligonucleotide-therapeutics)
*Product*
Target Specific Genes for Advanced Disease Treatment.

- **Oligonucleotide-Based Therapeutics** — Target Specific Genes
- **Customization of Therapeutics** — Create Tailored Treatments
- **Rapid Development Cycles** — Accelerate Development
- **Wide Range of Applications** — Address Diverse Diseases

### [Pediatric Sleep Apnea Testing Device](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/pediatric-sleep-apnea)
*Product*
Essential Device for Assessing Pediatric Sleep Apnea.

- **Pediatric Sleep Apnea Testing** — Detects Sleep Apnea In Children

### [Tracheal Acoustic Monitoring](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/tracheal-acoustic-monitoring)
*Product*
Enables real-time detection of respiratory airflow for better health monitoring.

- **Respiratory airflow monitoring** — Detects Airflow Instantly
- **Non-invasive Measurements** — Measures Without Surgery

### [Wearable for Knee Osteoarthritis](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/wearable-knee-osteoarthritis)
*Product*
Helps manage knee osteoarthritis through innovative wearable technology.

- **Knee Osteoarthritis Wearable** — Assists In Managing Pain
- **Real-Time Monitoring** — Enables Personalized Feedback
- **User-Friendly Interface** — Simplifies User Interaction

### [Haptica Robotics](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/haptica-robotics)
*Platform*
Enables efficient training of robots through remote operation.

- **Teleoperation Platform** — Enhances Training Efficiency
- **Real-Time Control** — Facilitates Immediate Corrections
- **User-Friendly Interface** — Simplifies Operation

### [Photonic Routers for Solid-State Imaging](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/photonic-routers-solid)
*Product*
Enhances solid-state imaging systems through advanced routing of photonic signals.

- **Photonic Routers** — Enable Efficient Signal Routing

### [Nanoscale Lithography](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/nanoscale-lithography)
*Product*
Enables Precise Nanoscale Patterning For Advanced Applications.

- **Nanoscale Patterning Capability** — Achieves High-Resolution Designs

### [Immersive Virtual Acoustic Spaces](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/Immersive-virtual-acoustic-spaces)
*Platform*
Create Realistic Audio Environments For Enhanced User Experiences.

- **Immersive Acoustic Spaces** — Facilitates Engaging Audio Environments
- **Real-time Audio Interaction** — Enables Dynamic Audio Adjustments
- **Cross-Platform Compatibility** — Increases Accessibility Across Devices

### [Magnefy](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/magnefy-predictive)
*Platform*
Enhances operational efficiency through predictive maintenance for power assets.

- **Predictive Maintenance for Power Assets** — Optimize Maintenance Scheduling
- **Data-Driven Insights** — Enhance Decision-Making
- **User-Friendly Interface** — Streamline User Access

### [Kerra](https://otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23sustainability/kerra-keratin-based)
*Platform*
Sustainable alternative to fossil fuels using keratin technology.

- **Keratin-based platform** — Reduces Fossil Fuel Dependency
- **Sustainability Focus** — Enhances Environmental Responsibility

## Market Segments

- **Surgical and interventional devices** (market size $60.0B, CAGR 6%): Devices for surgical and catheter-based interventions to repair or replace tissue and remove vascular obstructions.
- **Remote patient monitoring** (market size $28.6B, CAGR 11.2%): Capabilities that collect, visualize, and act on continuous biometric and patient-reported data to support at-home monitoring and clinician-led interventions.
- **Biopharmaceutical platforms and therapeutics** (market size $155.0B, CAGR 12.5%): Therapeutic platforms and next‑generation biologics including oligonucleotide therapies, universal vaccine platforms, and cell‑based treatments.
- **Advanced photonics and nanoscale fabrication** (market size $300.0B, CAGR 7.5%): Photonics and nanoscale patterning technologies for imaging, sensing, and micro/nanofabrication in electronics, photonics, and biomedical devices.
- **Industrial automation and control systems** (market size $275.0B, CAGR 9.6%): Integration of robotics, conveyors, custom machinery, UL-certified control panels and SCADA for production automation, real-time monitoring, and process optimization.